# BioAtla, Inc.: Form 8-K, filed Jan 12, 2026

- Company: [BioAtla, Inc.](/companies/bcab.md) (CIK 1826892)
- Form: 8-K
- Filed: 2026-01-12
- Accepted by EDGAR: Jan 12, 2026, 16:30 ET
- Period: 2026-01-09
- Accession: 0001193125-26-010458
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1826892/000119312526010458/bcab-20260109.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1826892/000119312526010458/

## Items reported

- Item 3.02: Unregistered sale of equity
- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1826892/000119312526010458/bcab-20260109.htm

Filed Jan 12, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-010458. Last ingested by Listed: Oct 30, 2026, 06:15 ET. No prices; not investment advice.
